Information Provided By:
Fly News Breaks for December 17, 2019
ICPT
Dec 17, 2019 | 07:39 EDT
Wells Fargo analyst Jim Birchenough raised his price target for Intercept to $146 from $120 and reiterated an Overweight rating following the company's NASH commercial day and on prospects for significant market opportunity for obeticholic acid in patients with NASH and advanced fibrosis. The analyst tells investors in a research note that he continues to believe that adoption of non-invasive testing remains a key value driver for Intercept and is encouraged by positive key opinion leader feedback.
News For ICPT From the Last 2 Days
There are no results for your query ICPT
I agree to the thefly.com's disclaimer & terms of use
About Privacy Terms of Use

© 1996-2018 TheStreet, Inc., 14 Wall Street, 15th Fl, NY, NY 10005

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.